Newly available urology products and services from Olympus, the National Institutes of Health, Spectrum Surgical Instruments Corp., and Midmark.
New LESS tools include instrument access port, videoscope
Center Valley, PA-Olympus recently introduced three surgical instruments designed specifically for laparo-endoscopic single-site surgery (LESS). The devices include the QuadPort, a disposable multi-instrument access port that can simultaneously accommodate up to four instruments through a single incision; the HiQ LS curved 5-mm hand instruments, which contain a shaft with curved distal and proximal ends to prevent interference with other LESS surgical devices inside the body; and the EndoEYE LS Laparo-Thoraco Videoscope, which incorporates a deflectable control section to help prevent interference with other devices externally.
For more information, visit http://www.olympusamerica.com/.
Bethesda, MD- http://ResearchMatch.org/ ( http://www.researchmatch.org/), a new, not-for-profit secure Web site, is a national research study recruitment registry. The site, created by medical research institutions affiliated with the National Institutes of Health, offers a free, safe, and easy-to-use way for volunteers to connect with thousands of researchers conducting research on diseases.
For more information, visit http://www.nih.gov/.
Internet-based tool provides detailed instrument repair tracking
For more information, visit http://www.spectrumsurgical.com/.
Mobile workstation helps integrate EMRs, other IT devices
For more information, visit http://www.midmark.com/.
Book discusses 'exploitation' of prostate cancer patients
Pittsburgh-The PSA test has led to the exploitation of prostate cancer patients, who are often treated unnecessarily following diagnosis, Anthony H. Horan, MD argues in his book, The Big Scare: The Business of Prostate Cancer. In the book, published by SterlingHouse Publisher Inc., Dr. Horan uses medical facts, statistics, and his own experience as a urologist to present his case on why the majority of prostate cancer patients should be treated with minimal cryosurgery or not be treated at all.
For more information, visit http://www.sterlinghousepublisher.com/.